These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31295543)

  • 21. Fat mass and obesity-associated protein attenuates lipid accumulation in macrophage foam cells and alleviates atherosclerosis in apolipoprotein E-deficient mice.
    Mo C; Yang M; Han X; Li J; Gao G; Tai H; Huang N; Xiao H
    J Hypertens; 2017 Apr; 35(4):810-821. PubMed ID: 28253220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TGF-beta reduced binding of high-density lipoproteins in murine macrophages and macrophage-derived foam cells.
    Zuckerman SH; Panousis C; Evans G
    Atherosclerosis; 2001 Mar; 155(1):79-85. PubMed ID: 11223429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the Combined Effect of Recombinant High-Density Lipoprotein Carrier and the Encapsulated Lovastatin in RAW264.7 Macrophage Cells Based on the Median-Effect Principle.
    Jiang C; Zhao Y; Yang Y; He J; Zhang W; Liu J
    Mol Pharm; 2018 Mar; 15(3):1017-1027. PubMed ID: 29382194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nucleolin protects macrophages from oxLDL-induced foam cell formation through up-regulating ABCA1 expression.
    Li Y; Jiang B; Liang P; Tong Z; Liu M; Lv Q; Liu Y; Liu X; Tang Y; Xiao X
    Biochem Biophys Res Commun; 2017 Apr; 486(2):364-371. PubMed ID: 28315324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversal of hypoxia in murine atherosclerosis prevents necrotic core expansion by enhancing efferocytosis.
    Marsch E; Theelen TL; Demandt JA; Jeurissen M; van Gink M; Verjans R; Janssen A; Cleutjens JP; Meex SJ; Donners MM; Haenen GR; Schalkwijk CG; Dubois LJ; Lambin P; Mallat Z; Gijbels MJ; Heemskerk JW; Fisher EA; Biessen EA; Janssen BJ; Daemen MJ; Sluimer JC
    Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2545-53. PubMed ID: 25256233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic Magnetic Resonance Imaging of Atherosclerosis in Apolipoprotein E Knockout Mouse Model Using Macrophage-Targeted Gadolinium-Containing Synthetic Lipopeptide Nanoparticles.
    Shen ZT; Zheng S; Gounis MJ; Sigalov AB
    PLoS One; 2015; 10(11):e0143453. PubMed ID: 26569115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kaempferol suppresses lipid accumulation in macrophages through the downregulation of cluster of differentiation 36 and the upregulation of scavenger receptor class B type I and ATP-binding cassette transporters A1 and G1.
    Li XY; Kong LX; Li J; He HX; Zhou YD
    Int J Mol Med; 2013 Feb; 31(2):331-8. PubMed ID: 23232972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulations of CD36 and Calpain-1, Inflammation, and Atherosclerosis by Simvastatin in Apolipoprotein E Knockout Mice.
    Yin M; Liu Q; Yu L; Yang Y; Lu M; Wang H; Luo D; Rong X; Tang F; Guo J
    J Vasc Res; 2017; 54(3):123-130. PubMed ID: 28448973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. siRNA nanoparticles targeting CaMKIIγ in lesional macrophages improve atherosclerotic plaque stability in mice.
    Tao W; Yurdagul A; Kong N; Li W; Wang X; Doran AC; Feng C; Wang J; Islam MA; Farokhzad OC; Tabas I; Shi J
    Sci Transl Med; 2020 Jul; 12(553):. PubMed ID: 32718990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
    Higashi Y; Sukhanov S; Shai SY; Danchuk S; Tang R; Snarski P; Li Z; Lobelle-Rich P; Wang M; Wang D; Yu H; Korthuis R; Delafontaine P
    Circulation; 2016 Jun; 133(23):2263-78. PubMed ID: 27154724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Scavenger receptor-AI-targeted iron oxide nanoparticles for in vivo MRI detection of atherosclerotic lesions.
    Segers FM; den Adel B; Bot I; van der Graaf LM; van der Veer EP; Gonzalez W; Raynal I; de Winther M; Wodzig WK; Poelmann RE; van Berkel TJ; van der Weerd L; Biessen EA
    Arterioscler Thromb Vasc Biol; 2013 Aug; 33(8):1812-9. PubMed ID: 23744990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapamycin-Loaded Biomimetic Nanoparticles Reverse Vascular Inflammation.
    Boada C; Zinger A; Tsao C; Zhao P; Martinez JO; Hartman K; Naoi T; Sukhoveshin R; Sushnitha M; Molinaro R; Trachtenberg B; Cooke JP; Tasciotti E
    Circ Res; 2020 Jan; 126(1):25-37. PubMed ID: 31647755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxidized LDL phagocytosis during foam cell formation in atherosclerotic plaques relies on a PLD2-CD36 functional interdependence.
    Ganesan R; Henkels KM; Wrenshall LE; Kanaho Y; Di Paolo G; Frohman MA; Gomez-Cambronero J
    J Leukoc Biol; 2018 May; 103(5):867-883. PubMed ID: 29656494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sugar-based amphiphilic nanoparticles arrest atherosclerosis in vivo.
    Lewis DR; Petersen LK; York AW; Zablocki KR; Joseph LB; Kholodovych V; Prud'homme RK; Uhrich KE; Moghe PV
    Proc Natl Acad Sci U S A; 2015 Mar; 112(9):2693-8. PubMed ID: 25691739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Porphyromonas gingivalis lipopolysaccharide increases lipid accumulation by affecting CD36 and ATP-binding cassette transporter A1 in macrophages.
    Li XY; Wang C; Xiang XR; Chen FC; Yang CM; Wu J
    Oncol Rep; 2013 Sep; 30(3):1329-36. PubMed ID: 23835648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Piezocatalytic Schottky Junction Treats Atherosclerosis by a Biomimetic Trojan Horse Strategy.
    Cheng J; Pan W; Zheng Y; Zhang J; Chen L; Huang H; Chen Y; Wu R
    Adv Mater; 2024 May; 36(19):e2312102. PubMed ID: 38289723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant HDL(Milano) exerts greater anti-inflammatory and plaque stabilizing properties than HDL(wild-type).
    Ibanez B; Giannarelli C; Cimmino G; Santos-Gallego CG; Alique M; Pinero A; Vilahur G; Fuster V; Badimon L; Badimon JJ
    Atherosclerosis; 2012 Jan; 220(1):72-7. PubMed ID: 22030095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Folate receptor–targeted single-photon emission computed tomography/computed tomography to detect activated macrophages in atherosclerosis: can it distinguish vulnerable from stable atherosclerotic plaques?
    Winkel LC; Groen HC; van Thiel BS; Müller C; van der Steen AF; Wentzel JJ; de Jong M; Van der Heiden K
    Mol Imaging; 2014; 13():. PubMed ID: 24757762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EP 80317, a CD36 selective ligand, promotes reverse cholesterol transport in apolipoprotein E-deficient mice.
    Bujold K; Mellal K; Zoccal KF; Rhainds D; Brissette L; Febbraio M; Marleau S; Ong H
    Atherosclerosis; 2013 Aug; 229(2):408-14. PubMed ID: 23880196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific Disruption of Abca1 Targeting Largely Mimics the Effects of miR-33 Knockout on Macrophage Cholesterol Efflux and Atherosclerotic Plaque Development.
    Price NL; Rotllan N; Zhang X; Canfrán-Duque A; Nottoli T; Suarez Y; Fernández-Hernando C
    Circ Res; 2019 Mar; 124(6):874-880. PubMed ID: 30707082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.